Edwards Lifesciences Corporation EW / BAN Stock

Overview Charts & Stats for the Selected Time Period

This overview page provides a quick summary of the selected assets, including their latest prices, price changes, market capitalization changes, and more.

Settings

Asset EW / BAN

Latest Price 211,663.9

Price Change % Calculating...

Price Change X Calculating...

Up Days Calculating...

Down Days Calculating...

Avg Up Day % Calculating...

Avg Down Day % Calculating...

Median Up Day % Calculating...

Median Down Day % Calculating...

Volatility % 13.03%

Win Rate % 64.4%

CAGR % +4,235,014.10%

Best Day % +64.97%

Worst Day % -16.62%

Max Drawdown % -20.50%

Period High 218,225.96

Period Low 55,100.91

From High % -1.9%

From Low % +288.4%

Sharpe Ratio 0.28

Days >Avg % 52.2%

Total Volume 332,284,615,177

Volume: 2026-02-17

Aggregate Volume: 46 Days

Price Chart Percentage Gains

The price chart compares the percentage returns for each asset in the given time period. Each starts out at 0% at the x axis left most position.

Price Overlay ChartPercentage Gains

The overlay price chart displays the price movements of each asset over the selected period, using individual y-axes for each. This allows for an easy comparison of assets with different magnitudes, making it great for identifying correlations.

Volume Chart Daily Volume

This volume chart shows the daily volume for each asset.

Learn More

This page just gave you an overview, you might also want to check out the comprehensive stats, historical, correlation, volatility, and price projection pages.

What is Edwards Lifesciences Corporation?

This company operates within the medical technology sector, focusing on developing and manufacturing innovative solutions for structural heart disease and critical care monitoring. Its primary offerings include artificial heart valves and minimally invasive surgical technologies designed to treat patients with a range of cardiovascular conditions. Key product lines encompass transcatheter aortic valve replacement (TAVR) systems, which are a less invasive alternative to traditional open-heart surgery for aortic stenosis. Additionally, the company provides advanced hemodynamic monitoring systems utilized in intensive care units to track vital patient data. These technologies address significant unmet medical needs and represent a growing segment of the cardiovascular care market. The company holds a prominent position as a global leader in its specialized field, driven by ongoing research and development efforts aimed at advancing patient outcomes and expanding treatment options for complex heart conditions. Its focus on innovation and patient-centric solutions underpins its market strength.

🤖 AI Analysis

Model:

Ask me anything about the data on this page. I can help explain metrics, identify patterns, or answer specific questions.

Data sources

Trade hundreds of crypto perpetual futures